Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA AUROBINDO PHARMA ASTRAZENECA PHARMA/
AUROBINDO PHARMA
 
P/E (TTM) x 94.6 23.0 411.4% View Chart
P/BV x 22.5 2.4 944.6% View Chart
Dividend Yield % 0.3 0.3 110.3%  

Financials

 ASTRAZENECA PHARMA   AUROBINDO PHARMA
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-23
AUROBINDO PHARMA
Mar-23
ASTRAZENECA PHARMA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs3,620715 506.5%   
Low Rs2,438397 613.6%   
Sales per share (Unadj.) Rs401.2424.2 94.6%  
Earnings per share (Unadj.) Rs39.732.9 120.7%  
Cash flow per share (Unadj.) Rs46.254.1 85.4%  
Dividends per share (Unadj.) Rs16.003.00 533.3%  
Avg Dividend yield %0.50.5 97.9%  
Book value per share (Unadj.) Rs234.4458.1 51.2%  
Shares outstanding (eoy) m25.00585.94 4.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.51.3 576.0%   
Avg P/E ratio x76.316.9 451.3%  
P/CF ratio (eoy) x65.510.3 638.1%  
Price / Book Value ratio x12.91.2 1,064.4%  
Dividend payout %40.39.1 441.8%   
Avg Mkt Cap Rs m75,718325,753 23.2%   
No. of employees `000NANA-   
Total wages/salary Rs m2,59135,223 7.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,030248,554 4.0%  
Other income Rs m2612,906 9.0%   
Total revenues Rs m10,291251,460 4.1%   
Gross profit Rs m1,24937,070 3.4%  
Depreciation Rs m16312,446 1.3%   
Interest Rs m61,405 0.4%   
Profit before tax Rs m1,34126,125 5.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3486,849 5.1%   
Profit after tax Rs m99319,277 5.2%  
Gross profit margin %12.514.9 83.5%  
Effective tax rate %26.026.2 99.0%   
Net profit margin %9.97.8 127.6%  
BALANCE SHEET DATA
Current assets Rs m9,359214,599 4.4%   
Current liabilities Rs m4,844114,938 4.2%   
Net working cap to sales %45.040.1 112.3%  
Current ratio x1.91.9 103.5%  
Inventory Days Days4921 239.9%  
Debtors Days Days3966 59.7%  
Net fixed assets Rs m2,061176,668 1.2%   
Share capital Rs m50586 8.5%   
"Free" reserves Rs m5,811267,813 2.2%   
Net worth Rs m5,861268,399 2.2%   
Long term debt Rs m06,190 0.0%   
Total assets Rs m11,421392,125 2.9%  
Interest coverage x213.919.6 1,091.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.6 138.5%   
Return on assets %8.75.3 165.9%  
Return on equity %16.97.2 235.9%  
Return on capital %23.010.0 229.3%  
Exports to sales %033.7 0.0%   
Imports to sales %37.415.3 244.0%   
Exports (fob) Rs mNA83,703 0.0%   
Imports (cif) Rs m3,74738,060 9.8%   
Fx inflow Rs m61285,483 0.7%   
Fx outflow Rs m3,74741,447 9.0%   
Net fx Rs m-3,13544,036 -7.1%   
CASH FLOW
From Operations Rs m58323,868 2.4%  
From Investments Rs m181-39,778 -0.5%  
From Financial Activity Rs m-24518,144 -1.3%  
Net Cashflow Rs m5192,298 22.6%  

Share Holding

Indian Promoters % 0.0 48.8 -  
Foreign collaborators % 75.0 3.1 2,443.0%  
Indian inst/Mut Fund % 5.4 41.3 13.1%  
FIIs % 2.7 20.7 12.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 48.2 51.9%  
Shareholders   29,032 241,944 12.0%  
Pledged promoter(s) holding % 0.0 20.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs Aurobindo Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs Aurobindo Pharma Share Price Performance

Period ASTRAZENECA PHARMA Aurobindo Pharma S&P BSE HEALTHCARE
1-Day -0.92% 1.89% 1.18%
1-Month -4.51% 6.04% -0.75%
1-Year 57.72% 113.22% 61.82%
3-Year CAGR 20.13% 7.80% 18.16%
5-Year CAGR 21.96% 7.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the Aurobindo Pharma share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of Aurobindo Pharma.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 16.0 per share. This amounted to a Dividend Payout ratio of 40.3%.

Aurobindo Pharma paid Rs 3.0, and its dividend payout ratio stood at 9.1%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of Aurobindo Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.